Status:

UNKNOWN

Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections

Lead Sponsor:

University Hospital, Linkoeping

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Complicated Intra-Abdominal Infections

Eligibility:

All Genders

18+ years

Brief Summary

The objectives of the study were: 1. To study risk factors for colonization and infection with antibiotic resistant bacteria among patients with severe IAI before and after antibiotic treatment and s...

Detailed Description

In order to evaluate if standard empirical treatment was adequate in relation to resistance pattern among most prevalent species at admission we need another 70 patients to be included with at least d...

Eligibility Criteria

Inclusion

  • Patients with evidence of intra-abdominal infections that require surgical intervention will be eligible.
  • In addition will patients with intra-abdominal abscess confirmed with CT/ultrasound be eligible, but not treated with surgical intervention if estimated to require at least 5 days antibiotic treatment, with a severity needing initial intravenous administration of antibiotics.

Exclusion

  • Age under 18 years

Key Trial Info

Start Date :

February 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2009

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00860587

Start Date

February 1 2006

End Date

October 1 2009

Last Update

March 12 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.